Literature DB >> 16176258

Control of the coagulation system by serpins. Getting by with a little help from glycosaminoglycans.

Robert N Pike1, Ashley M Buckle, Bernard F le Bonniec, Frank C Church.   

Abstract

Members of the serine protease inhibitor (serpin) superfamily play important roles in the inhibition of serine proteases involved in complex systems. This is evident in the regulation of coagulation serine proteases, especially the central enzyme in this system, thrombin. This review focuses on three serpins which are known to be key players in the regulation of thrombin: antithrombin and heparin cofactor II, which inhibit thrombin in its procoagulant role, and protein C inhibitor, which primarily inhibits the thrombin/thrombomodulin complex, where thrombin plays an anticoagulant role. Several structures have been published in the past few years which have given great insight into the mechanism of action of these serpins and have significantly added to a wealth of biochemical and biophysical studies carried out previously. A major feature of these serpins is that they are under the control of glycosaminoglycans, which play a key role in accelerating and localizing their action. While further work is clearly required to understand the mechanism of action of the glycosaminoglycans, the biological mechanisms whereby cognate glycosaminoglycans for each serpin come into contact with the inhibitors also requires much further work in this important field.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16176258     DOI: 10.1111/j.1742-4658.2005.04880.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  34 in total

1.  Finding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s).

Authors:  Arjun Raghuraman; Philip D Mosier; Umesh R Desai
Journal:  J Med Chem       Date:  2006-06-15       Impact factor: 7.446

2.  Engineered virus-like nanoparticles reverse heparin anticoagulation more consistently than protamine in plasma from heparin-treated patients.

Authors:  Andrew J Gale; Darlene J Elias; Patricia M Averell; Paul S Teirstein; Mitchell Buck; Steven D Brown; Zinaida Polonskaya; Andrew K Udit; M G Finn
Journal:  Thromb Res       Date:  2011-04-14       Impact factor: 3.944

3.  Longitudinal observations of serum heparin cofactor II-thrombin complex in treated Mucopolysaccharidosis I and II patients.

Authors:  Lorne Andrew Clarke; Harmony Hemmelgarn; Karen Colobong; Anita Thomas; Sylvia Stockler; Robin Casey; Alicia Chan; Paul Fernoff; John Mitchell
Journal:  J Inherit Metab Dis       Date:  2011-07-06       Impact factor: 4.982

4.  Tumor biomarker glycoproteins in the seminal plasma of healthy human males are endogenous ligands for DC-SIGN.

Authors:  Gary F Clark; Paola Grassi; Poh-Choo Pang; Maria Panico; David Lafrenz; Erma Z Drobnis; Michael R Baldwin; Howard R Morris; Stuart M Haslam; Sophia Schedin-Weiss; Wei Sun; Anne Dell
Journal:  Mol Cell Proteomics       Date:  2011-10-10       Impact factor: 5.911

5.  Identification of Serpinb6b as a species-specific mouse granzyme A inhibitor suggests functional divergence between human and mouse granzyme A.

Authors:  Dion Kaiserman; Sarah E Stewart; Kim Plasman; Kris Gevaert; Petra Van Damme; Phillip I Bird
Journal:  J Biol Chem       Date:  2014-02-06       Impact factor: 5.157

6.  Toward a robust computational screening strategy for identifying glycosaminoglycan sequences that display high specificity for target proteins.

Authors:  Nehru Viji Sankaranarayanan; Umesh R Desai
Journal:  Glycobiology       Date:  2014-07-21       Impact factor: 4.313

7.  Beating tissue factor at its own game: Design and properties of a soluble tissue factor-independent coagulation factor VIIa.

Authors:  Anders B Sorensen; Inga Tuneew; L Anders Svensson; Egon Persson; Henrik Østergaard; Michael Toft Overgaard; Ole H Olsen; Prafull S Gandhi
Journal:  J Biol Chem       Date:  2019-12-04       Impact factor: 5.157

8.  The Caenorhabditis elegans muscle specific serpin, SRP-3, neutralizes chymotrypsin-like serine peptidases.

Authors:  Stephen C Pak; Christopher Tsu; Cliff J Luke; Yuko S Askew; Gary A Silverman
Journal:  Biochemistry       Date:  2006-04-11       Impact factor: 3.162

9.  A novel protein C inhibitor gene mutation in pediatric stroke patients after bone marrow transplantation.

Authors:  Didem Torun; Gülhis Deda; Mehmet Ertem; Zümrüt Uysal; Erkan Yılmaz; Nejat Akar
Journal:  Mol Biol Rep       Date:  2013-05-14       Impact factor: 2.316

Review 10.  Extracellular matrix turnover and outflow resistance.

Authors:  Kate E Keller; Mini Aga; John M Bradley; Mary J Kelley; Ted S Acott
Journal:  Exp Eye Res       Date:  2008-12-06       Impact factor: 3.467

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.